Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen. [electronic resource]
Producer: 20000601Description: 2037-41 p. digitalISSN:- 0008-543X
- Adult
- Age Factors
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cause of Death
- Cerebellar Diseases -- chemically induced
- Cytarabine -- administration & dosage
- Death, Sudden, Cardiac -- etiology
- Disease-Free Survival
- Drug Eruptions -- etiology
- Exanthema -- chemically induced
- Female
- Humans
- Injections, Intravenous
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Neoplasm Recurrence, Local -- drug therapy
- Neutropenia -- chemically induced
- Remission Induction
- Thrombocytopenia -- chemically induced
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.